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Abstract 
In November 2002, a virus known as SARS-CoV was identified in Guangdong, China, and it was implicated 
as the etiology of severe acute respiratory syndrome. Seventeen years later, in the same month of 
November, a similar disease with more dramatic outcomes was identified in neighboring Wuhan.  It has 
been six months since the identification of first cases of COVID-19 pandemic; however, unveiling clinical 
characteristics and modes of transmission of the disease are taking longer than expected. This overview 
aims to highlight some important points regarding the mode of transmission for which continuously 
surprising facts are being revealed every day. We also raise some vital questions to alert the scientific 
community to find the right answers and minimize the drastic fatal outcomes of this disease. It can be stated 
that SARS-CoV-2 could be transmitted as aerosol infection as well as through contacting infected surfaces. 
The possible role of abdominal gases as a route of spread of the virus should be considered and a fecal 
sample might be a useful diagnostic tool. Moreover, medical face masks are not protective from virus 
transmission during treating COVID-19 patients in settings where aerosol-generating procedures are 
performed. Doffing of PPE for healthcare workers needs more attention as this might be a source of 
infection unless additional measures of PPE disinfection are employed before doffing. 
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Introduction 
It was November 2002 when a virus known as SARS-CoV was identified in Guangdong Province, 
China, and it was implicated as the etiological virus in severe acute respiratory syndrome (SARS). Seventeen 
years later, almost in the same month of November, a similar disease with more dramatic outcomes was 
identified in the neighboring Wuhan city. Coronaviruses are enveloped single‐stranded large RNA viruses that 
infect both humans and animals. The name “corona” (crown in Latin) is attributed to the spherical shape of the 
core-shell and its surface projections resembling the solar corona. Four subfamilies of coronaviruses are 
identified; alpha‐, beta‐, gamma‐ and delta‐coronaviruses [1]. It is thought that beta‐coronaviruses originate 
from mammals, with bats being suspected due to similarity in the genome sequence of SARS-CoV-2, which is 
more than 90% similar to a Bat-CoV-RaTG13. In fact, a wide variety of coronaviruses are naturally occurring 
in bats, including SARS-CoV-like and MERS-CoV like viruses. The beta‐coronaviruses are known to cause 
severe disease and fatalities. 
Healthcare personnel should be experts in cross-infection control and barrier techniques. However, 
the multiple modes of COVID-19 transmission had been a continuous threat to the lives of all those working 
for care of COVID-19 patients. Some reports emerged from different countries indicating infection and even 
death of healthcare workers [2]. COVID-19 cases were estimated to be 8,944,481, while deaths were estimated 
to be 467,282 affecting more than 213 countries worldwide (last updated 21-6-2020, 11.21 GMT) [3]. 
WHO launched hundreds of free training courses to support millions on its different platforms 
through Health Emergencies Program, United Nations Crisis Management Team (UN CMT), Regional 
Updates, COVID-19 web page and daily reports web page. More facts about COVID-19 transmission and 
effective preventive measures should be revealed and disseminated among the medical community to preserve 
the precious lives of healthcare team members [4]. WHO released recently on 4 March 2020 a worldwide 
Surveillance Protocol among health care workers (HCW) and its aim was to identify the most appropriate 
infection control prevention measures to protect HCW [5]. 
In this critical review, we refer to the most recent update on modes of transmission of SARS-CoV-2 
and the evidence base for effective cross-infection control measures in the clinical settings. We also raise some 
vital questions that the scientific community should tackle to find the right answers and minimize the drastic 
fatal outcomes of this disease. 
 
Modes of Transmission and Clinical Manifestations 
Modes of transmission of the virus can be described as being various. Close or direct contact with 
infected secretions or respiratory droplets produced by coughing, sneezing or talking, represent the major 
transmission route. Other modes of transmission include touching surfaces contaminated with the virus and 
touching mouth/nose/eyes [6]. 
Pneumonia was the initial clinical manifestation of COVID‐19, which led to a description of this 
disease as an acute respiratory infection. So in the first instance, this disease was looked at as a respiratory 
infection, which only causes pulmonary manifestations. More recent reports also describe asymptomatic 
infections, neurological, and gastrointestinal symptoms. It is estimated that the majority of individuals infected 
by SARS‐CoV‐2 (80%) remain asymptomatic throughout infection. In symptomatic patients, after an 
incubation period of less than one week on average, infection is manifested as fever, fatigue, dyspnea, and 
myalgia, which later progresses to pneumonia in the second or third week of infection. There will be reduced 
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oxygen saturation, and chest radiographic pathology manifested as ground-glass abnormalities, patchy 
consolidation, alveolar exudates and interlobular involvement. On the other hand, the pediatric population is 
influenced less severely than adults by SARS-CoV-2, wherein 2% only of the affected patients are younger than 
19 years [7]. Similar to adults, few children may be asymptomatic carriers; however, the most common clinical 
manifestations include fever and cough with less frequent manifestations, including typical manifestations of 
viral infection (fatigue, myalgia, headache, dizziness), respiratory virus infections (nasal congestion, runny 
nose, sneezing, sore throat), and gastrointestinal manifestations (vomiting, and abdominal pain) [8]. 
Moreover, SARS-CoV-2 appears to induce a late phase hyper-inflammatory syndrome similar to 
Kawasaki disease (mucocutaneous lymph node syndrome), which is a multisystem disorder characterized by 
fever and vasculitis. Studies that reported this association in children described the following manifestations of 
mucocutaneous involvement: cracked lip, skin rash, conjunctivitis and edematous hands and feet [9]. 
The extrapulmonary symptoms of the disease are now well recognized with the involvement of the 
liver, kidney, and even multisystem organ failure and acute cardiac arrest, which lead to sudden death of 
people, some of them were unfortunately spotted dying in the streets [10,11]. Approximately 50% of patients 
present with liver abnormalities in the form of elevated liver enzymes; however, the exact etiology of liver 
damage could be either due to COVID-19 infection or an adverse effect of antiviral drugs used for treatment 
[12]. Furthermore, it was noticed that the functional receptor of SARS-CoV-2, angiotensin-converting 
enzyme 2 (ACE2), is highly expressed in the bile duct's epithelial cells compared to hepatocytes or other 
interstitial cells [13]. 
Of special interest are the orofacial manifestations of the disease. Loss of smell and taste was reported 
in an Italian study where it was noticed that a substantial proportion of COVID-19 patients had lost taste 
and/or smell [14]. It is thought that the high availability of the virus in saliva [15] and its interaction with 
ACE2 receptor, which is widely expressed in the brain and oral mucosa (particularly the tongue) [16], are 
responsible for these manifestations. More recently, two case series were reported from Spain and France to 
explain the possible association between COVID-19 and oral ulcerations [17,18]. In these reports, some 
patients were not confirmed cases of COVID-19, and no investigations were done to exclude other viruses like 
the Herpes viruses, which are known to cause oral ulcers [19]. Therefore, the possibility that oral ulcers 
affecting patients in these reports are coincidental findings and that they were caused by another virus is valid. 
The disease's gastrointestinal symptoms represent an important and interesting type of 
extrapulmonary symptoms, particularly when mode of transmission is concerned. While the mode of 
transmission of infection is respiratory, the fecal-oral route of transmission has now been identified and is 
suspected to be the mode of transmission in many studies [13]. The virus’s nucleic acid has been detected in 
the feces of some COVID-19 patients indicating that live viruses are present in the feces and confirming that 
fecal-oral route of transmission is implicated [13]. ACE2 is known to be abundant in enterocytes (the 
intestinal lining epithelial cells) all over the small intestine including the duodenum, jejunum, and ileum, but 
were not detected in enterocytes of the colon or stomach [20]. Immunofluorescence showed that ACE2 was 
abundantly expressed in the glandular cells of the stomach, duodenum and rectum of infected patients [21]. It 
can thus be concluded that gastrointestinal cells of infected people do secret the virions [21]. Prevalence of 
diarrhea, nausea, vomiting, or abdominal discomfort is estimated to be approximately 5% [13]. 
Coronaviruses were mainly detected in fecal samples from bats but not in oral swabs, which implicates 
a predominantly gastrointestinal viral replication in bats [22]. The likely emergence of new coronaviruses 
from bats was already highlighted by scientists previously, and this was attributed to the fact that certain 
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coronaviruses found in bats were able to infect humans without prior adaptation [23]. Based on this likely 
emergence, scientists warned against the lack of clinical data necessary for provision of effective treatment, 
which will compromise efforts to fight a pandemic when it arises [24]. 
These gastrointestinal symptoms precede respiratory symptoms in a substantial number of COVID-19 
patients. Observations reported from clinicians caring for infected isolated patients, revealed expulsion of 
excess colonic gas, which has an unpleasant odor with or without diarrhea [25,26]. The intestinal gas content 
is mainly dependent on gas production by bacterial fermentation of unabsorbed substrates. Hence, it is 
plausible to say that the virus may modify the intestinal bacteria in COVID-19 patients through infection of 
the intestinal lining epithelium. Further, it was found that live SARS‐ CoV‐ 2 may exist in fecal specimens of 
patients with negative oropharyngeal specimens [27]. This indicates that viral infection of the gastrointestinal 
tract can persist longer way after virus is cleared from the respiratory tract [21]. Abdominal gases could be a 
route of spread of the virus that needs further investigations and a fecal sample might be a useful diagnostic 
tool. Other unusual recognized symptoms that may affect the gastrointestinal tract include loss of taste, which 
could also be accompanied by loss of smell [10,28]. 
 
Factors Affecting the Viability of Virus 
Some advice of using hot drinks was thought to be sufficient to kill the virus in the pharynx; however, 
after that, this appeared not correct due to reports that said it could withstand up to 56°C degree [11,25]. 
In the beginning, it was reported that virus is large in size and is not airborne spreading and it falls 
after 3 hours on grounds and surfaces. It is not an aerosol transmitted infection, so only infection control 
precautions and social distancing for at least one meter is enough to prevent the spread of the infection. Still, 
after a while, some researchers reported that it could be transmitted as an airborne infection that spread for 
more than 4 meters in the air [26]. 
Most human coronaviruses are transmitted by direct contact with infected secretions or by a 
respiratory mode of transmission. Bronchoalveolar lavage fluid samples and oral swabs were positive for 
SARS-CoV-2 using quantitative PCR and conventional PCR suggestive of a respiratory route. Stool samples 
may also be positive, and nosocomial spread is of main concern. Interpersonal transmission of SARS-CoV-2 
occurs mainly between family members and close friends due to intimate contact with patients or 
asymptomatic carriers. Spread of SARS-CoV-2 through the respiratory tract, is achieved by droplets, 
respiratory secretions, and direct contact. The multiple possible routes of transmission could be explained by 
the fact that ACE2 receptor is abundantly present on epithelial cells of lung alveoli and enterocytes of small 
intestine. So far, clinical diagnosis of COVID-19 can be accurately achieved by identifying the viral nucleic acid 
in the nose, throat, or other respiratory tract using swab sampling followed by real-time PCR, further 
confirmed by next-generation sequencing. 
 
Effective PPE for SARS-CoV-2 
A total number of 425 infected cases were investigated demonstrating that the number of infected 
individuals may double every one week since each patient can spread infection to an average of 2.2 other 
individuals (R0, or the expected number of secondary cases produced by a single (typical) infection in a 
completely susceptible population). This estimate is close to SARS‐CoV, which caused an outbreak in 2003 and 
was associated with an R0 of 3 9. This indicates how serious is the transmission of COVID-19, which is 
classified as a high airborne consequence of infectious disease in the UK. 
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Face masks are a primary type of personal protective equipment that protects the nose and mouth 
from spread of respiratory infections, making it and effective method to prevent transmission of respiratory 
microorganisms [29]. 
Recommendations of mandatory face masks use by symptomatic patients and healthcare workers were 
consistent since the outset of the pandemic; however, there was some controversy over their use in the general 
public and community settings. It was noticed that the advice of the US Surgeon General was against the use 
of face masks by healthy people. This was mainly due to two reasons; to discourage consumption of face masks, 
and preserve the limited supplies which are much needed for healthcare professionals, and also it was argued 
that face masks provide no effective protection against coronavirus infection. Recommendations from the UK 
and Germany are based on the scarcity of the evidence that supports the role of face masks in providing 
effective protection against respiratory infections in the public setting [30]. On the other hand, healthcare 
workers are largely dependent on face masks as part of droplet precautions when caring for patients with 
respiratory infections. At this time, it is recommended that vulnerable individuals stay safe by avoiding crowds 
and using surgical face masks rationally when exposed to high-risk area.  
Indeed, COVID-19 could be transmitted from asymptomatic carriers; thus, it would be wise to reduce 
community transmission if everyone, including asymptomatic carriers, wears face masks. It is also important to 
note that face masks should be used appropriately, with the replacement of disposable masks, to maintain the 
protective effect of these masks. People in quarantine should wear face masks if they need to leave home for any 
reason, since some of them may be asymptomatic carriers who can pose a threat to others. Vulnerable 
populations of older adults and medically compromised patients are at particular risk and those should wear 
face masks if available. After easing lockdown, many countries now have announced that wearing face masks is 
mandatory [29]. 
Regular medical masks appeared to be enough at the beginning to prevent Coronavirus cross-infection 
among HCWs.  Medical health workers who depend on this type only during treatment of COVID-19 patients 
are susceptible to infection and hence we saw a large number of medical staff infected by the virus in different 
countries like Egypt, Italy, and USA. These types of masks alone without a complete face shield are not 
adequate with active coronavirus [30,31]. WHO launched updated guidelines concerning effectiveness and 
advice in mask use on 5 June 2020, which developed by guidance development group (COVID-19 IPC GDG), 
and concluded from various systematic reviews that the use of N95 Respirator is more protective against 
Aerosol Generating Procedures (AGP) during setting for treating COVID-19 patients? Medical masks should 
be used continuously combined with face shields to avoid risk of transmission from splashes or droplets to the 
eyes during healthcare shift of treating symptomatic COVID-19 patients in other non-AGPs [32]. 
It is important to address the different aspects of face masks that need further research like duration of 
effectiveness of fabric or cloth masks, the measures to increase the effectiveness of disposable masks, and the 
invention of reusable masks [32]. Donning and doffing of PPE strictly following correct sequence does not 
guarantee coronavirus prevention, the mask is the last removed PPE. To prevent transmission from 
contaminated parts, it is recommended that PPE undergo disinfection in a special room assigned for disposal of 
used PPE. 
 
Conclusion 
This overview was conducted about mode of transmission of pandemic coronavirus (COVID-19) crisis, 
which still has surprising facts every day. Coronavirus could be transmitted as aerosol infection and not only 
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through contact infected surfaces. Abdominal gases could be a route of spread of the virus and a fecal sample 
might be a useful diagnostic tool. Medical face masks are not protective from coronavirus during treating 
COVID-19 patients in a setting where aerosol-generating procedures are performed. There is a lack of 
evidence that fabric or cloth masks are protective for healthcare workers. Doffing of PPE for healthcare 
workers needs more attention as this might be a source of infection unless extra methods of disinfection of PPE 
before doffing are implicated. 
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